Page last updated: 2024-08-24

glucose, (beta-d)-isomer and Ventricular Dysfunction

glucose, (beta-d)-isomer has been researched along with Ventricular Dysfunction in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Furukawa, S; Hiasa, Y; Matsuura, B; Miki, T; Miura, T; Ohnishi, H; Sato, T; Tanno, M1
Chen, HL; Chen, JX; Guo, ZY; Jiang, W; Li, P; Li, RL; Wang, X; Wang, XL; Wang, XX; Xiong, LL; Zhu, Y1

Other Studies

2 other study(ies) available for glucose, (beta-d)-isomer and Ventricular Dysfunction

ArticleYear
Longitudinal impact of dapagliflozin treatment on ventricular repolarization heterogeneity in patients with type 2 diabetes.
    Journal of diabetes investigation, 2019, Volume: 10, Issue:6

    Topics: Benzhydryl Compounds; Diabetes Mellitus, Type 2; Follow-Up Studies; Glucosides; Humans; Longitudinal Studies; Middle Aged; Prognosis; Prospective Studies; Sodium-Glucose Transporter 2 Inhibitors; Ventricular Dysfunction

2019
Salidroside improves doxorubicin-induced cardiac dysfunction by suppression of excessive oxidative stress and cardiomyocyte apoptosis.
    Journal of cardiovascular pharmacology, 2013, Volume: 62, Issue:6

    Topics: Animals; Antibiotics, Antineoplastic; Antioxidants; Apoptosis; Cardiotonic Agents; Cell Line; Cell Size; Cell Survival; Clone Cells; Doxorubicin; Gene Expression Regulation, Enzymologic; Glucosides; Heart Ventricles; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Oxidative Stress; Oxidoreductases; Phenols; Random Allocation; Rats; Ventricular Dysfunction

2013